Data / Drug companies / Plasma derivatives
Companies that list plasma derivatives products: 33 companies and 304 products in the FDA NDC directory
The FDA National Drug Code Directory lists 304 products that are plasma derivatives from 33 companies. The ten largest listers hold 71.1% of them, and the newest started marketing on August 31, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 33Companies
- 304Products
- 67Drugs by generic name
- Biologics (BLA)Main marketing category
Companies with the most plasma derivatives
Ranked by number of products in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Takeda Pharmaceuticals America, Inc. | 48 | kit; injection, solution | Biologics (BLA) | July 14, 2025 |
| Octapharma USA Inc | 24 | solution; kit | Biologics (BLA) | June 23, 2025 |
| Novo Nordisk | 22 | kit | Biologics (BLA) | February 19, 2019 |
| Grifols USA, LLC | 21 | kit; injection, solution | Biologics (BLA) | November 15, 2023 |
| Pfizer Laboratories Div Pfizer Inc | 21 | solution | Biologics (BLA) | November 13, 2023 |
| Grifols USA, LLC | 19 | solution; kit | Biologics (BLA) | December 16, 2025 |
| Kedrion Biopharma, Inc. | 17 | kit; solution | Biologics (BLA) | November 8, 2017 |
| Bioverativ Therapeutics Inc. | 16 | kit | Biologics (BLA) | September 6, 2017 |
| CSL Behring AG | 14 | liquid; solution | Biologics (BLA) | January 1, 2020 |
| Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC | 14 | kit | Biologics (BLA) | February 1, 2012 |
| Baxter Healthcare Corporation | 12 | kit; solution | Biologics (BLA) | March 19, 2008 |
| CSL Behring Lengnau AG | 12 | kit | Biologics (BLA) | May 30, 2018 |
| CSL Behring GmbH | 11 | kit; injection, solution | Biologics (BLA) | June 22, 2017 |
| Bayer HealthCare LLC | 10 | kit | Biologics (BLA) | December 2, 2024 |
| Grifols USA, LLC | 6 | kit; solution | Biologics (BLA) | November 1, 2019 |
| Pfizer Laboratories Div Pfizer Inc | 6 | kit; liquid | Biologics (BLA) | August 31, 2026 |
| Kamada Ltd. | 5 | injection, solution; liquid | Biologics (BLA) | October 1, 2025 |
| CSL Behring | 3 | kit | Biologics (BLA) | April 24, 2019 |
| Fisher Clinical Services Inc. | 3 | kit | Biologics (BLA) | July 31, 2023 |
| BTG International Inc. | 2 | injection, powder, lyophilized, for solution | Biologics (BLA) | August 31, 2001 |
| Emergent BioSolutions Canada Inc. | 2 | liquid | Biologics (BLA) | October 5, 2015 |
| Ethicon, Inc | 2 | powder, for solution; patch | Biologics (BLA) | March 1, 2013 |
| Kedrion Biopharma, Inc. | 2 | injection, powder, lyophilized, for solution; solution | Biologics (BLA) | July 1, 2025 |
| Rare Disease Therapeutics, Inc | 2 | injection, powder, lyophilized, for solution | Biologics (BLA) | May 6, 2015 |
| Takeda Pharmaceuticals America, Inc. | 2 | injection, powder, lyophilized, for solution; kit | Biologics (BLA) | January 15, 2021 |
| Bio Products Laboratory Ltd | 1 | solution | Biologics (BLA) | April 7, 2017 |
| Biotest AG | 1 | solution | Biologics (BLA) | March 1, 2025 |
| GC Biopharma Corp. | 1 | liquid | Biologics (BLA) | December 15, 2023 |
| Kedrion Biopharma Inc | 1 | injection, solution | Biologics (BLA) | March 9, 2007 |
| Kedrion S.p.A | 1 | injection, solution | Biologics (BLA) | September 15, 2011 |
| Merck Sharp & Dohme LLC | 1 | kit | Biologics (BLA) | December 1, 2014 |
| Pharmacia & Upjohn Company LLC | 1 | injection, solution | Biologics (BLA) | November 17, 1981 |
| Salvagenix Inc. | 1 | injection, powder, lyophilized, for solution | Biologics (BLA) | March 20, 2026 |
Drugs most often listed
| Drug | Products here | Companies listing it |
|---|---|---|
| Albumin (human) | 17 | 6 |
| Human immunoglobulin g | 13 | 5 |
| Antihemophilic factor (recombinant) | 29 | 4 |
| Coagulation factor ix (recombinant) | 10 | 3 |
| Immune globulin intravenous (human) | 9 | 3 |
| Albumin human | 5 | 3 |
| Immune globulin (human) | 5 | 3 |
| Human rho(d) immune globulin | 3 | 3 |
| Antihemophilic factor recombinant | 11 | 2 |
| Immune globulin | 11 | 2 |
| Antihemophilic factor/von willebrand factor complex (human) | 8 | 2 |
| Immunoglobulin g | 7 | 2 |
| Human c1-esterase inhibitor | 5 | 2 |
| Alpha-1-proteinase inhibitor (human) | 4 | 2 |
| Immune globulin intravenous, human - dira | 2 | 2 |
| Ovine digoxin immune fab | 2 | 2 |
| Hepatitis b immune globulin (human) | 1 | 2 |
| Latrodectus mactans | 1 | 2 |
| Antihemophilic factor (human) | 12 | 1 |
| Fibrinogen human, human thrombin | 12 | 1 |
| Antihemophilic factor (recombinant), fc fusion protein | 10 | 1 |
| Coagulation factor viia (recombinant) | 8 | 1 |
| Antihemophilic factor (recombinant) pegylated | 7 | 1 |
| Antihemophilic factor (recombinant), glycopegylated-exei | 7 | 1 |
| Antihemophilic factor, human recombinant | 7 | 1 |
| Coagulation factor ix (human) | 6 | 1 |
| Coagulation factor ix (recombinant), fc fusion protein | 6 | 1 |
| Thrombin, topical (bovine) | 6 | 1 |
| Antihemophilic factor (recombinant) pegylated-aucl | 5 | 1 |
| Coagulation factor ix recombinant human | 5 | 1 |
| Antihemophilic factor human | 4 | 1 |
| Human fibrinogen, human thrombin | 4 | 1 |
| Human plasma proteins | 4 | 1 |
| Alpha-1-proteinase inhibitor human kit | 3 | 1 |
| Factor ix complex | 3 | 1 |
| Fibrinogen (human) | 3 | 1 |
| .alpha.1-proteinase inhibitor human | 2 | 1 |
| Antithrombin iii (human) | 2 | 1 |
| Fibrinogen human | 2 | 1 |
| Human hepatitis b virus immune globulin | 2 | 1 |
| Immune globulin infusion (human) | 2 | 1 |
| Protein c concentrate human | 2 | 1 |
| Rho(d) immune globulin (human) | 2 | 1 |
| Von willebrand factor (recombinant) | 2 | 1 |
| Alpha-1-proteinase inhibitor human | 1 | 1 |
| Alpha.1-proteinase inhibitor human | 1 | 1 |
| Alpha1-proteinase inhibitor (human) | 1 | 1 |
| Anthrax immune globulin (human) | 1 | 1 |
| Antihemophilic factor (recombinant), porcine sequence | 1 | 1 |
| Centruroides (scorpion) immune f(ab)2 (equine) | 1 | 1 |
| Coagulation factor xiii a-subunit (recombinant) | 1 | 1 |
| Crotalidae immune f(ab)2(equine) | 1 | 1 |
| Equine thymocyte immune globulin | 1 | 1 |
| Factor xiii concentrate (human) | 1 | 1 |
| Fibrinogen human and human thrombin | 1 | 1 |
| Fibrinogen, human-chmt | 1 | 1 |
| Human cytomegalovirus immune globulin | 1 | 1 |
| Human rabies virus immune globulin | 1 | 1 |
| Human varicella-zoster immune globulin | 1 | 1 |
| Immune globulin subcutaneous (human) | 1 | 1 |
| Immune globulin subcutaneous, human-klhw | 1 | 1 |
| Ovine crotalidae venoms immune fab | 1 | 1 |
| Plasma protein fraction (human) | 1 | 1 |
| Plasminogen | 1 | 1 |
| Rabies immune globulin (human) | 1 | 1 |
| Tetanus immune globulin (human) | 1 | 1 |
| Thrombin human | 1 | 1 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.